What is river blindness?
Stories | September 1, 2020
River blindness – or onchocerciasis – is one of the leading causes of blindness worldwide. It has a devastating impact on the lives of people primarily living in tropical African nations.
The parasitic disease can be transmitted to humans if they are repeatedly bitten by an infected blackfly. Blackflies are most commonly found in close proximity to fast-flowing streams and rivers.
An adult female worm produces larval worms (microfilariae) within an infected human body, causing significant damage to the person’s eyes and skin. Symptoms range from itching, inflammation and skin lesions through to eye lesions that can lead to permanent visual impairment and blindness.
More than 99 per cent of people who suffer from river blindness live in 31 African countries including Kenya, Ethiopia, Sudan, South Sudan, Uganda, Ghana and Nigeria.
The Global Burden of Disease Study estimated that, in 2017, there were over 20 million active infections and more than one million people who had experienced vision impairment or loss.
Fortunately, there is hope for a brighter future. River blindness was successfully eliminated from three Latin American countries over the past decade due to an effective, inexpensive medication.
What are the symptoms?
Common inflammatory symptoms of river blindness occur when tiny larval worms die within the human body. Infected people may experience:
- Severe itching and/or skin rashes
- Skin lesions due to the loss of elasticity
- The development of nodules under the skin
- Disfiguring skin diseases due to loss of pigment
- Vision impairment and blindness.
What is the treatment?
The introduction of powerful and effective medication, Mectizan, in 1987 has shown it is possible to transform the lives of millions of disadvantaged people living with river blindness.
Mectizan kills the larval worms that live within an infected person, gradually reducing the inflammatory symptoms of the disease.
It is not a quick fix – it is estimated that a person must take Mectizan on an annual basis for up to 18 years to completely break transmission of the microfilariae.
However, the success of the medication speaks for itself. CBM played a role in the successful elimination of river blindness in Colombia (2013), Ecuador (2014) and Guatamala (2016).
Positive progress has been made in parts of Africa, particularly Uganda and Sudan, which are closest to elimination.
Your $80 gift will protect children from this terrible disease and will be multiplied by seven this Christmas thanks to a partner organisation.
Farewell Sue Reid: Celebrating over 20 years of dedicated service to CBM and volunteers
Almost 24 years ago, Sue Reid joined CBM Australia...
Training healthcare workers in Nigeria to treat and prevent obstetric fistula
For most women, giving birth to a child is...
The Sendai Framework mid-term review – how far have we come on disability inclusion?
This week, governments are attending a high-level United Nations...